Radiation with or without temozolomide is standard adjuvant treatment for GBM.10 We hypothesized that, as an important mechanism of resistance to DNA-damaging therapies, elevated PKM2 expression should be associated with decreased overall survival in GBM patients. Here, PKM is linked to glioblastoma.